Gangnamunni
6 known investors
Korean aesthetic-medicine platform, operated by Healing Paper, connecting users with clinics for treatment information and bookings.
Also known as Gangnam Unni · GangnamUnni · Healing Paper · UNNI · 강남언니
Investors · 6
Also in the syndicate · 3
Company profile
researched Aug 2026Gangnamunni (강남언니) is an aesthetic and beauty medical platform operated by the South Korean company Healing Paper. The service helps users research and select clinics and treatments, publishing user reviews, editorial guides and price comparisons, and enabling consultations and bookings with participating hospitals. The consumer site lists individual procedures from named clinics — spanning hair transplants and scalp treatments, rhinoplasty and other cosmetic surgery, injectables and skin boosters — with list prices, discounted prices, VAT-inclusive amounts, clinic locations (largely Seoul districts such as Apgujeong, Gangnam and Sinsa, plus Busan, Daegu, Suwon and other regional sites), and per-procedure user ratings and review counts. Clinics that meet review-based criteria are flagged with a monthly "customer-rated excellent hospital" designation.
Beyond the consumer marketplace, the company sells B2B tools to aesthetic medical clinics, including CRM software and photography equipment intended to support customer management and clinic marketing. Internationally, the platform operates under the UNNI brand for global users, offering hospital reservation services both for foreign patients travelling to Korean clinics and for local users booking at clinics in the markets it has entered.
An EquityZen profile describing the company frames its positioning around reducing information asymmetry in medical decision-making through transparent medical information combined with an IT platform, and cites accumulated user reviews and app-mediated hospital consultations as its core assets.
Business model
The platform aggregates aesthetic clinics and their procedures, presenting reviews, guides and discounted procedure prices to consumers while providing participating clinics with customer acquisition and marketing exposure; the company also sells B2B products to clinics, specifically CRM software and photography equipment for customer management and marketing.
Sources describe consumer-facing procedure listings from partner clinics with discounted pricing and paid B2B clinic solutions (CRM software and photography equipment); specific pricing or fee mechanics are not detailed.
Traction
Launched in 2015, the platform reports 7 million cumulative users across its multilingual services as of February 2025. An EquityZen profile cites approximately one million accumulated user reviews, 3.8 million individuals who have used the app for hospital consultations, and 1.6 million completed cases.
Latest developments
In February 2025 Healing Paper closed a KRW 42.8 billion Series C round (reported as $32 million and, at the stated rate of US$1 = KRW1,439.67, as $29.7 million), led by Korea Investment Partners with Shinhan Venture Investment, KT Investment, IMM Investment and Kiwoom Investment, and follow-on participation from Premier Partners, Intervest, Aju IB Investment and DSC Investment; Korea Investment Partners joined the board. Proceeds are earmarked for global expansion, including Thailand, and for scaling B2B clinic solutions. A press mention dated October 2025 reports that UNNI added Chinese language support.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned as an aesthetic medical platform with 7 million cumulative users across Korean, Japanese, English and Thai language versions, described by investors in its Series C as having demonstrated performance in Korea and Japan with potential to scale globally.
Combines a large base of user-generated reviews and transparent treatment and price information with clinic booking, and pairs the consumer marketplace with clinic-side CRM and photography tools; management frames the mission as reducing information asymmetry in the aesthetic medical industry.
Technology
A multilingual mobile app and web platform combining a user review database, treatment information and clinic booking/consultation workflows, plus clinic-facing CRM software; EquityZen lists the company under software, artificial intelligence, and data and analytics industries.
Go-to-market
Consumer app and web platform with install incentives (a coupon pack offered on first app installation), first-visit trial pricing, editorial selection guides and user reviews; clinic-side acquisition through marketplace listings and B2B software and equipment offerings; international growth via localized language versions of the UNNI service.
Consumers researching aesthetic and cosmetic medical procedures in Korea, Japan and Thailand, including inbound foreign patients seeking Korean clinics, and, on the B2B side, aesthetic medical clinics and hospitals.
Geography
Headquartered in South Korea with clinic listings across Seoul and regional Korean cities including Busan, Daegu, Suwon, Anyang and Namyangju. International expansion began with Japan in November 2019, and a Thai-language version of the global UNNI service launched in November 2024 with expansion underway in Thailand. The platform is available in Korean, Japanese, English and Thai; Chinese language support was reported added in October 2025.
History
Gangnamunni launched in 2015 as an aesthetic medical platform operated by Healing Paper. It began international expansion in November 2019 with Japan, offering hospital reservations for foreign patients visiting Korean clinics and for local users booking Japanese clinics. In November 2024 it launched a Thai-language version of its global UNNI service and began expanding in Thailand, and in February 2025 it announced a Series C round to fund global growth and B2B clinic products. An EquityZen listing states a founding year of 2012.
Risks & controversies
The company's stated focus on addressing information asymmetry and negative perceptions of plastic surgery reflects reputational sensitivities in the aesthetic medicine sector; no specific disputes or regulatory actions are reported in the available material.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 4
launches, deals, and filingsA press mention lists the addition of Chinese language support to the UNNI service.
Healing Paper, operator of Gangnamunni, announced completion of a KRW 42.8 billion Series C round (reported as $32 million; $29.7 million at the stated rate of US$1 = KRW1,439.67), led by Korea Investment Partners, Shinhan Venture Investment, KT Investment, IMM Investment and Kiwoom Investment, with follow-on investment from Premier Partners, Intervest, Aju IB Investment and DSC Investment. Korea Investment Partners joined the board of directors. Funds are directed at global expansion and B2B clinic solutions.
$32M source ↗
Launched a Thai-language version of its global service, UNNI, and began expanding its presence in Thailand.
The platform expanded internationally starting with Japan, providing hospital reservation services for foreign patients visiting Korean hospitals and for local users seeking treatment at Japanese clinics.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- Gangnamunnigangnamunni.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Gangnamunni do?
- Korean aesthetic-medicine platform, operated by Healing Paper, connecting users with clinics for treatment information and bookings.
- Who are Gangnamunni's investors?
- Gangnamunni's investors include Atinum Investment Co. Ltd., Kiwoom Investment, KT investment Inc..